Fig. 5: Effect of OMT on gut microbiota and LPS levels. | Nutrition & Diabetes

Fig. 5: Effect of OMT on gut microbiota and LPS levels.

From: A promising approach to diabetic osteoporosis: oxymatrine’s effects on gut microbiota and osteoblasts

Fig. 5

A Venn diagram of model, control and OMT groups (n = 4 for each group). B β-diversity measured by PLS-DA (Partial Least Squares Discriminant Analysis) (n = 4 for each group). C, D α-diversity analysis based on Chao 1 and Sobs indices (n = 4 for each group), *p < 0.05. E Average composition of the phylum, in each group (n = 4 for each group). F The relative abundance of Firmicutes, Bacteroidota, Actinobacteriota in each group, the different letters represent significant differences between different groups (n = 4 for each group, p < 0.05). G Identified families and genera in the Gram‑negative phylum Bacteroidetes with high relative abundances. H The relative abundance of Bacteroides, Porphyromonas, Prevotella, Paraprevotella and Flavobacterium in each group (n = 4 for each group), **p < 0.01, *p < 0.05. I Effects of OMT on LPS level of Serum and feces (n = 4 for each group), #p < 0.05 compared with the control group (n = 4 for each group), *p < 0.05 compared with the model group. Comparison among multiple groups was analyzed by ANOVA (followed by Tukey’s post hoc test). All experiments were repeated at least three times.

Back to article page